Search alternatives:
targeted therapeutics » targeted therapeutic (Expand Search), targeted therapies (Expand Search), based therapeutics (Expand Search)
decrease therapeutic » increased therapeutic (Expand Search), degrader therapeutics (Expand Search), great therapeutic (Expand Search)
host resistance » plant resistance (Expand Search)
decrease host » decreases short (Expand Search)
targeted therapeutics » targeted therapeutic (Expand Search), targeted therapies (Expand Search), based therapeutics (Expand Search)
decrease therapeutic » increased therapeutic (Expand Search), degrader therapeutics (Expand Search), great therapeutic (Expand Search)
host resistance » plant resistance (Expand Search)
decrease host » decreases short (Expand Search)
-
121
-
122
-
123
-
124
-
125
-
126
Data_Sheet_1_Antimicrobial Peptides Derived From Insects Offer a Novel Therapeutic Option to Combat Biofilm: A Systematic Review.docx
Published 2021“…It covers the AMP composition, pathways and mechanisms of action, the formation of biofilms, impact of biofilms on human diseases, current strategies as well as therapeutic options to combat biofilm with antimicrobial peptides from insects. …”
-
127
-
128
Presentation_1_Classification of expert-level therapeutic decisions for degenerative cervical myelopathy using ensemble machine learning algorithms.pdf
Published 2022“…</p>Conclusion<p>ML-based classification of DCM therapeutic options is valid and feasible. This study can be a basis for establishing generalizable ML-based surgical decision models for DCM. …”
-
129
Examination of CD302 as a potential therapeutic target for acute myeloid leukemia
Published 2019“…These studies provide the foundation for examining CD302 as a potential therapeutic target for AML.</p></div>…”
-
130
-
131
-
132
-
133
Image1_Potential of Novel Methyl Jasmonate Analogs as Anticancer Agents to Metabolically Target HK-2 Activity in Glioblastoma Cells.tif
Published 2022“…<p>Change in the energy metabolism of cancer cells, which display significant differences compared to normal cells, is a rising phenomenon in developing new therapeutic approaches against cancers. One of the metabolic enzymes, hexokinase-II (HK-II) is involved in glycolysis, and inhibiting the HK-II activity may be a potential metabolic target for cancer therapy as most of the drugs in clinical use act on DNA damage. …”
-
134
-
135
-
136
Image_3_Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma.TIFF
Published 2020“…<p>Adrenocortical carcinomas (ACC) are aggressive tumors with a heterogeneous prognosis and limited therapeutic options for advanced stages. This study aims to identify novel drug targets for a personalized treatment in ACC. …”
-
137
Image_2_Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma.TIFF
Published 2020“…<p>Adrenocortical carcinomas (ACC) are aggressive tumors with a heterogeneous prognosis and limited therapeutic options for advanced stages. This study aims to identify novel drug targets for a personalized treatment in ACC. …”
-
138
Image_5_Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma.TIFF
Published 2020“…<p>Adrenocortical carcinomas (ACC) are aggressive tumors with a heterogeneous prognosis and limited therapeutic options for advanced stages. This study aims to identify novel drug targets for a personalized treatment in ACC. …”
-
139
Image_1_Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma.TIFF
Published 2020“…<p>Adrenocortical carcinomas (ACC) are aggressive tumors with a heterogeneous prognosis and limited therapeutic options for advanced stages. This study aims to identify novel drug targets for a personalized treatment in ACC. …”
-
140
Image_4_Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma.TIFF
Published 2020“…<p>Adrenocortical carcinomas (ACC) are aggressive tumors with a heterogeneous prognosis and limited therapeutic options for advanced stages. This study aims to identify novel drug targets for a personalized treatment in ACC. …”